GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CytoSorbents Corp (STU:HQE1) » Definitions » Cyclically Adjusted PB Ratio

CytoSorbents (STU:HQE1) Cyclically Adjusted PB Ratio : 1.36 (As of Jun. 10, 2024)


View and export this data going back to 2011. Start your Free Trial

What is CytoSorbents Cyclically Adjusted PB Ratio?

As of today (2024-06-10), CytoSorbents's current share price is €0.775. CytoSorbents's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €0.57. CytoSorbents's Cyclically Adjusted PB Ratio for today is 1.36.

The historical rank and industry rank for CytoSorbents's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:HQE1' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.22   Med: 16.16   Max: 1185
Current: 1.34

During the past years, CytoSorbents's highest Cyclically Adjusted PB Ratio was 1185.00. The lowest was 1.22. And the median was 16.16.

STU:HQE1's Cyclically Adjusted PB Ratio is ranked better than
64.84% of 475 companies
in the Medical Devices & Instruments industry
Industry Median: 2.1 vs STU:HQE1: 1.34

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

CytoSorbents's adjusted book value per share data for the three months ended in Mar. 2024 was €0.321. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.57 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


CytoSorbents Cyclically Adjusted PB Ratio Historical Data

The historical data trend for CytoSorbents's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CytoSorbents Cyclically Adjusted PB Ratio Chart

CytoSorbents Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 247.42 18.52 4.10 1.78

CytoSorbents Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.60 7.07 3.31 1.78 1.43

Competitive Comparison of CytoSorbents's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, CytoSorbents's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CytoSorbents's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CytoSorbents's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CytoSorbents's Cyclically Adjusted PB Ratio falls into.



CytoSorbents Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

CytoSorbents's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.775/0.57
=1.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CytoSorbents's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, CytoSorbents's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.321/131.7762*131.7762
=0.321

Current CPI (Mar. 2024) = 131.7762.

CytoSorbents Quarterly Data

Book Value per Share CPI Adj_Book
201406 -0.547 100.560 -0.717
201409 -0.649 100.428 -0.852
201412 0.138 99.070 0.184
201503 0.362 99.621 0.479
201506 0.414 100.684 0.542
201509 0.331 100.392 0.434
201512 0.297 99.792 0.392
201603 0.221 100.470 0.290
201606 0.136 101.688 0.176
201609 0.048 101.861 0.062
201612 0.050 101.863 0.065
201703 -0.057 102.862 -0.073
201706 0.250 103.349 0.319
201709 0.279 104.136 0.353
201712 0.299 104.011 0.379
201803 0.391 105.290 0.489
201806 0.587 106.317 0.728
201809 0.544 106.507 0.673
201812 0.468 105.998 0.582
201903 0.412 107.251 0.506
201906 0.316 108.070 0.385
201909 0.189 108.329 0.230
201912 0.094 108.420 0.114
202003 0.534 108.902 0.646
202006 0.587 108.767 0.711
202009 1.578 109.815 1.894
202012 1.507 109.897 1.807
202103 1.500 111.754 1.769
202106 1.425 114.631 1.638
202109 1.381 115.734 1.572
202112 1.274 117.630 1.427
202203 1.157 121.301 1.257
202206 1.033 125.017 1.089
202209 0.906 125.227 0.953
202212 0.765 125.222 0.805
202303 0.617 127.348 0.638
202306 0.503 128.729 0.515
202309 0.390 129.860 0.396
202312 0.393 129.419 0.400
202403 0.321 131.776 0.321

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CytoSorbents  (STU:HQE1) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


CytoSorbents Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of CytoSorbents's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CytoSorbents (STU:HQE1) Business Description

Traded in Other Exchanges
Address
305 College Road East, Princeton, NJ, USA, 08540
CytoSorbents Corp is involves in the treatment of life-threatening conditions in the intensive care (ICU) and cardiac surgery using blood purification via proprietary polymer adsorption technology. It has a number of products commercialized and in development based on this technology platform.

CytoSorbents (STU:HQE1) Headlines

No Headlines